Invitrogen KnockOut™血清替代物|無(wú)血清培養(yǎng)基10828-028

產(chǎn)品名稱：KnockOut™血清替代物，KnockOut™Serum Replacement，Knockout™SR，無(wú)血清培養(yǎng)基

品牌：Invitrogen

貨號(hào)：10828-028

規(guī)格：500ML

保存溫度：-5°C - -30°C

市場(chǎng)價(jià)格：3648元

特惠價(jià)格：2700元

 庫(kù)存狀態(tài)：現(xiàn)貨

供應(yīng)商：上海慧穎生物科技有限公司

Cell Type：Stem Cells (Embryonic)

Product Size：500 ml

Classification：Serum-Free    

Invitrogen KnockOut™血清替代物|無(wú)血清培養(yǎng)基10828-028

KnockOut™ 血清替代物(KnockOut™Serum Replacement) (Knockout™SR) 是成分確定的無(wú)血清制劑，適合未分化ES 細(xì)胞培養(yǎng)物的生長(zhǎng)和維持(1)。 可直接替代現(xiàn)有方案中的FBS。 與Knockout™D-MEM 一起使用時(shí)，Knockout™SR 的性能將得到增強(qiáng)。 通過(guò)評(píng)估產(chǎn)品在滅活的小鼠胚胎成纖維細(xì)胞上支持未分化D3 ES 細(xì)胞群生長(zhǎng)的能力來(lái)驗(yàn)證其性能。

Invitrogen KnockOut™血清替代物|無(wú)血清培養(yǎng)基10828-028

Description

 Gibco™ KnockOut™ Serum Replacement (KnockOut™ SR) is a more defined, FBS-free medium supplement that supports the growth of pluripotent stem cells (PSCs) cultured on fibroblast feeder cells. Designed to replace fetal bovine serum (FBS) in existing protocols, this serum replacement has been trusted by many for almost 20 years. Providing the documents required for regulatory review, KnockOut SR reduces your burden in qualifying reagents when transitioning from research applications to clinical applications. If you are interested in only basic research applications, see the Research Use Only version of this product to ensure that you receive the benefits and pricing that fit your needs.

 With KnockOut Serum Replacement, you can:

 • Culture feeder-dependent PSCs with confidence

 • Rely on the improved performance of a qualified, FBS-free formulation

 • Enjoy the peace of mind of having a more stable price and supply compared to FBS

Culture PSCs with confidence

 KnockOut SR has been cited in more than 2000 publications. It has been shown to support feeder-dependent culture of embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs). It has also been shown to support reprogramming, embryoid body (EB) formation, in vitro differentiation, cryopreservation, ESC derivation, and many other applications.

Rely on improved performance

 KnockOut SR has more a defined formulation compared to FBS, which contains many undefined and variable components. Unlike most FBS products, each lot is tested for its ability to support PSCs. Because of this, culturing PSCs with KnockOut SR leads to less differentiation and more compact colony morphology compared to FBS.

Enjoy the peace of mind of having stable price and supply

KnockOut SR is not affected by the limited supply and fluctuating prices often seen with FBS. This makes it easier to plan your budget and buy what you need, especially since it is more affordable than most FBS products.

 This reagent is classified as a medical device in several countries. If it is not regulated as a medical device in a specific region, it should be used for laboratory use only.